Main content

Strong Medicine

Peter Day visits two Swiss pharmaceutical companies, one huge and one tiny and linked by their quest for a treatment for Alzheimer's, to look at the future of drug discovery.

Big problems loom over the pharmaceutical industry which influences so many people's lives. Giant corporations are beset by scandal and their pipelines of new treatments are running dry. Peter Day looks at the future of the industry through the eyes of two Swiss pharma companies, one very big and one of them tiny. Both are linked by their quest for a treatment for Alzheimers.

Producer: Sandra Kanthal.

Available now

30 minutes

Last on

Sun 9 Dec 2012 21:30

Contributors to this programme

Severin Schwan

CEO, Roche

Andreas Knierzinger

Head Treasury and Financing, Roche

Michael Owen

Chairman, Sami Consulting

Luca Santerelli

Head of Neuroscience, Roche

Andrea Pfeifer

CEO, AC Immune

Broadcasts

  • Thu 6 Dec 2012 20:30
  • Sun 9 Dec 2012 21:30

Download this programme

Subscribe to this programme or download individual episodes.